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Autophagy is an intracellular mechanism whereby pathogens, particularly viruses, are
destroyed in autolysosomes after their entry into targets cells. Therefore, to survive and
replicate in host cells, viruses have developed multiple strategies to either counteract or
exploit this process. The aim of this review is to outline the known relationships between
HIV-1 and autophagy in CD4+ T lymphocytes and macrophages, two main HIV-1 cell tar-
gets. The differential regulation of autophagy in these two cell-types is highlighted and its
potential consequences in terms of viral replication and physiopathology discussed.
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INTRODUCTION
Although progress has been made in the global ﬁght against
HIV/AIDS, more than 33 million people are still living with HIV
worldwide (data from UNAIDS, 2009). HIV infection is character-
ized by an acute phase with very high levels of circulating viruses
and a rapid decline in CD4+ T cells. Despite a strong immune
response, the host cannot clear the infection and during the ensu-
ing long, clinically latent phase, CD4+ T cells are progressively
lost, eventually leading to AIDS in untreated patients. Long-lived,
latent HIV reservoirs, established early during infection, prevent
complete virus eradication although the anti-viral therapy effec-
tively reduces the plasmaHIV levels below detection limits (Chang
and Altfeld, 2010; Mogensen et al., 2010). As a consequence, the
ﬁght against HIV is very difﬁcult and a better understanding of
the relationship between HIV and the human innate and adaptive
immune systems is needed for the discovery of new drugs. Indeed,
at present, drugs block the virus life cycle at different steps (entry,
reverse transcription, integration, maturation) but do not act on
the host response, which is responsible for the establishment of
the reservoirs.
Macroautophagy (hereafter referred to as autophagy) is a phys-
iologically controlled intracellular degradation mechanism that
plays a role in both innate and adaptive immunity. Cytoplas-
mic pathogens can be degraded by autophagy, a process that has
been termed xenophagy (Deretic and Levine, 2009). Moreover,
autophagy participates in antigen processing for their presenta-
tion via the major histocompatibility complex (MHC) class I and
II proteins (Schmid and Munz, 2007; English et al., 2009; Lune-
mann and Munz, 2009). As an evolutionary counterpoint, certain
pathogens, including HIV-1, can inhibit or subvert autophagy to
replicate more efﬁciently (Espert et al., 2007; Levine and Deretic,
2007).
HIV-1 can infect different types of immune cells that express
CD4 and a coreceptor,mainly CCR5 or CXCR4 [i.e., CD4+T lym-
phocytes, macrophages, monocytes, and dendritic cells (DCs)],
but replicates efﬁciently only in CD4+ T cells and macrophages,
indicating that several aspects of the virus–host relationship are
different in these target cell populations. Although both CD4+ T
cells and macrophages are infected by HIV-1 and produce large
amounts of virions, many differences have been identiﬁed at each
step of the HIV-1 life cycle in these target cells (Table 1). The ulti-
mate difference of the complex relationship between host cell and
HIV-1 is the death of CD4+ T cells by apoptosis and the resistance
of macrophages to HIV-1 cytopathic effects (Carter and Ehrlich,
2008). This review summarizes the most recent information on
the regulation and the role of autophagy during HIV-1 infection
of CD4+ T cells and macrophages and proposes that the differen-
tial regulation of autophagy in these target cells might contribute
to HIV-1 physiopathology.
HIV-1 INFECTION OF CD4+ T CELLS AND MACROPHAGES
HIV-1 ENTRY IN CD4+ T CELLS AND MACROPHAGES
HIV-1 envelope (Env), composed of the glycoproteins gp120 and
gp41, plays a crucial role in virus entry. In most instances, to
enter a target cell, HIV-1 Env gp120, which is expressed at the
surface of free virions and infected cells, must bind to CD4.
The interaction between gp120 and CD4 triggers conforma-
tional changes leading to increased exposure of gp120 regions
(including the V3 loop) that can bind to CCR5 or CXCR4 (Pier-
son and Doms, 2003). Finally, interaction of gp120 with the
coreceptor induces a structural rearrangement of the transmem-
brane Env subunit gp41 and insertion of the fusion domain at
the N-terminus of gp41 into the target cell membrane. At this
stage, gp41 adopts a trimeric extended pre-hairpin intermediate
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Table 1 | Major differences between CD4+T lymphocytes and macrophages during HIV-1 infection.
HIV-1 entry HIV-1 replication Cell fate
C
D
4+
T
ly
m
ph
oc
yt
es
Interaction of Env with HIV-1 receptors
Efﬁcient HIV-1 spread through viral
synapses
HIV-1 receptors-dependent
endocytosis (productive infection)
Syncytia observed in vitro
Rapid synthesis of viral
DNA
Uninfected
cells
Viral genome integration
depends on cell activation
Apoptosis
Modulation of gene
expression
Infected cells
HIV-1 spread
ReservoirsBudding at the cell surface
Susceptibility to X4 and R5
strains
M
ac
ro
ph
ag
es
Interaction of Env with HIV-1 receptors
and potential additional membrane
components
HIV-1 receptors-independent
endocytosis (unproductive infection)
No syncytia observed in vitro
Slower synthesis of viral
DNA
Uninfected
cells
Viral genome integration is
independent of cell division
Resistance to
apoptosis
Modulation of gene
expression
Infected cells
HIV-1 spread
ReservoirsBudding in endosomes and at
the cell surface
Greater susceptibility to R5
strains
conformation before the formation of a stable six-helix bundle
structure and virus/cell-to-cell fusion.
Infection by cell-free viruses or through contact between
infected and uninfected cells leads to HIV-1 spread (Satten-
tau, 2008), but the efﬁciency of HIV-1 infection is higher when
the virus is delivered through cell-to-cell contacts. DCs and
macrophages, which are among the ﬁrst cells encountering HIV-
1, efﬁciently transmit HIV-1 to CD4+ T cells through viro-
logical synapses (McDonald et al., 2003; Arrighi et al., 2004;
Groot et al., 2008; Felts et al., 2010). This way of spread also
occurs between HIV-1-infected and uninfected CD4+ T cells
(Jolly et al., 2004; Rudnicka et al., 2009). In vitro, cell-to-cell
fusion leads to the formation of giant, multinucleated cells called
syncytia.
Coreceptor (CCR5 or CXCR4) use is correlated, at least in part,
with the different phases of the disease. R5 viruses, which utilize
CCR5, are predominantly isolated during the early stages of HIV-
1 infection. The emergence in a patient of X4 variants, which use
CXCR4, is almost invariably associated with faster decline of cir-
culating CD4+ T cells, accelerated disease progression and poor
prognosis for survival (Koot et al., 1993; Richman and Bozzette,
1994). However, the presence of X4 viruses is not an obligatory
prerequisite for disease progression and a signiﬁcant proportion of
individuals who progress to AIDS harbor exclusively R5 variants.
The selective transmission of R5 viruses is not fully understood,
but it may depend on the superimposition of multiple imperfect
gatekeepers that restrict HIV-1 X4 transmission at different steps
of the infection process (Margolis and Shattock, 2006).
Only about 15–30%of CD4+T lymphocytes express detectable
levels of CCR5 at the cell surface, whereas CXCR4 is expressed
on nearly all of these T cells (Bleul et al., 1997; Grivel and
Margolis, 1999). High levels of CCR5 are observed in acti-
vated/memory CD4+ T cells, which are the CD4+ T cells that
can be productively infected. In addition, the ﬁrst CD4+ T
cells to undergo intense HIV-1 replication after infection are
the resting memory CD4+ T cells present in the gut-associated
lymphoid tissue (GALT), which also express CCR5 (Li et al.,
2005).
Macrophages are also infected by X4 and R5 strains through
its receptors, CD4, CXCR4, and CCR5. However, they are more
frequently infected by HIV-1 R5 strains. This phenomenon is not
fully understood, but one explanation is that R5 strains can exploit
low levels of CD4 and/or CCR5 to entermacrophages (Peters et al.,
2004, 2006).
Besides this route of entry, endocytosis of HIV-1 has been
described, especially in macrophages. Most virions are subse-
quently degraded, but productive infection may nevertheless
occur through this CD4-independent mechanism (Marechal et al.,
2001). Entry by endocytosis has also been described in CD4+ T
cells, but in such cells it requires the presence of CD4 and leads to
productive infection (Pauza and Price, 1988). Recently, Miyauchi
et al. (2009) have demonstrated that HIV-1 likely enters lymphoid
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cells via an endocytic pathway, and that fusion between Env and
its receptors occur in intracellular compartments.
Additional membrane components may support HIV-1 entry
in macrophages, including syndecan, a heparan sulfate proteogly-
can (Saphire et al., 2001; de Parseval et al., 2005); gp340, a cysteine-
rich scavenger receptor (Wuet al., 2004); themacrophagemannose
receptor (Larkin et al., 1989; Chehimi et al., 2003; Nguyen and
Hildreth, 2003); elastase (Bristow et al., 2003); and α-v-integrin
(Bosch et al., 2006). These constituents may facilitate virus attach-
ment, binding, entry and/or fusion. Another potential membrane
ligand of HIV-1 is annexin II,which is expressed on themembrane
of macrophages, but not of T cells. Annexin II, which binds to
phosphatidyl serine (PS), an anionic phospholipid captured dur-
ing HIV-1 budding, contributes to the early events of macrophage
HIV-1 infection (Ma et al., 2004). Other candidate host cell sur-
face proteins that are incorporated in HIV-1 membranes and are
potentially needed for HIV-1 entry might include CD28, CD44,
and CD62L (Herzberg et al., 2006).
HIV-1 REPLICATION
After reaching the cytoplasm of the infected cell, HIV-1 reverse
transcription takes place in the reverse transcription complex
(RTC) that is constituted by virion core proteins, cellular pro-
teins, and the RNA genome (McDonald et al., 2002; Nermut
and Fassati, 2003). Double-stranded DNA is synthesized within
a few hours in CD4+ T cells, whereas this process is slower in
macrophages (Collin and Gordon, 1994; O’Brien et al., 1994).
The RTC moves along the microtubule network to reach the
microtubule organizing center (MTOC) and the nucleus. The
viral DNA is then imported into the nucleus and integrated
in the cell genome through a process that requires mitosis in
CD4+ T cells but not in macrophages. This suggests that cellu-
lar rather than viral components of the preintegration complex
(PIC), in which the viral DNA is associated with many proteins,
may play a major role in viral nuclear import and integration in
macrophages (Yamashita and Emerman, 2005). After integration
of the viral genome, most of the assembling HIV-1 particles local-
ize at the plasma membrane in infected CD4+ T cells, whereas
in macrophages viral particles are mostly concentrated in appar-
ently internal compartments that possess the characteristics of
late endosomes/multivesicular bodies (LEs/MVBs). However, a
fraction of the intracellular virus-containing compartments in
macrophages could be large and complex invaginations of the
plasma membrane (Deneka et al., 2007; Jouve et al., 2007; Welsch
et al., 2007).
Several microarray studies also indicate that HIV-1 infection
leads to changes in host gene expression, depending on the target
cell-type. Speciﬁcally,modulationof genes associatedwith the host
defense, signal transduction, cell cycle transcription, and arrest
occurs predominantly in HIV-1-infected macrophages (Coberley
et al., 2004; Vazquez et al., 2005). This differential modulation of
gene expression contributes to the greater survival of macrophages
in comparison to CD4+ T cells following HIV-1 infection (Giri
et al., 2006). Transcription of the HIV-1 DNA is also a highly reg-
ulated process that exploits the speciﬁc environment of the cell
host and involves multiple interplays between cell and viral factors
(Rohr et al., 2003).
HIV-1 INFECTION AND APOPTOSIS OF CD4+ T CELLS
Acute HIV-1 infection leads to a dramatic decrease in the num-
ber of CD4+ T cells, which then return to normal level in the
majority of patients. Afterward, the asymptomatic phase is char-
acterized by a progressive and continuous decline in the level
of circulating CD4+ T cells. In contrast, macrophages are more
resistant to HIV-1 cytopathic effects and their number is stable
over years, although several macrophage functions are affected
by HIV-1 infection (Biggs et al., 1995; Yoo et al., 1996; Polyak
et al., 1997; Kumar et al., 1999). CD4+ T lymphocyte depletion
is due to continued and accelerated apoptosis, probably triggered
by multifactorial mechanisms (Espert et al., 2006; Cummins and
Badley, 2010). HIV-1-induced apoptosis in bystander, uninfected
immune cells is likely to be a key factor in the gradual deple-
tion of T lymphocytes observed in HIV-1-infected patients, since
the degree of cell loss largely exceeds the number of infected cells.
Furthermore, the vast majority of CD4+T cells undergoing apop-
tosis in peripheral blood and lymph nodes of HIV-1 patients are
uninfected (Krammer et al., 1994; Finkel et al., 1995; Doitsh et al.,
2010).
Among the HIV-1 proteins known to induce apoptosis of
CD4+ T cells, cumulative data have demonstrated a major role of
Env in apoptosis of uninfected, bystander lymphocytes (Laurent-
Crawford et al., 1993; Heinkelein et al., 1995; Ohnimus et al., 1997;
Blanco et al., 1999, 2000; Roggero et al., 2001; Roshal et al., 2001;
Ahr et al., 2004). Indeed, binding of Env to its receptors constitutes
the primary interface between HIV-1 and its target cells, and both
HIV-1 X4 and R5 Env can induce CD4+ T cell death (Joshi et al.,
2011). Although interaction of gp120 with CD4 and the corecep-
tor is required for apoptosis induction, Env-mediated apoptosis
of target CD4+ T cells is induced through the fusogenic func-
tion of gp41. Interestingly, hemifusion, an intermediate step in the
fusion process characterized by the merger of the outer membrane
leaﬂets of two biological membranes without the formation of a
fusion pore or mixing of the inner leaﬂets, is sufﬁcient to trig-
ger Env-mediated apoptosis of bystander CD4+ T cells (Garg and
Blumenthal, 2006, 2008; Garg et al., 2007).
Many fundamental questions remain unsolved, such as how
host factors can inﬂuence the susceptibility to HIV-1 infection
and resistance to death and what are the mechanisms leading to
the establishment and maintenance of HIV-1 latency. This latter
point is of major importance because the latent viral reservoirs,
which are constituted mainly of resting CD4+ T cells (Chun et al.,
1995, 1997; Finzi et al., 1997; Wong et al., 1997; Siliciano et al.,
2003) and cells of the monocyte–macrophage lineage (Folks et al.,
1988; Biswas et al., 1992, 1994; Coleman and Wu, 2009), are unaf-
fected by highly active anti-retroviral therapies (HAART; Finzi
et al., 1999) and can reinitiate systemic infectionupon interruption
of HAART, or following the development of resistance (Marcello,
2006; Suyama et al., 2009).
AUTOPHAGY DURING HIV-1 INFECTION OF CD4+ T CELLS
AND MACROPHAGES
Autophagy is a highly regulated mechanism that involves spe-
ciﬁc genes called Atg (autophagy-related genes) and has an
essential role in cell homeostasis. Accordingly, autophagy has
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been implicated in several pathologies, including cancer, neu-
rodegeneration, and myopathies (Marino and Lopez-Otin, 2004).
Autophagy has also a specialized function in the innate immune
response against intracellular pathogens through their degrada-
tion in autolysosomes (Deretic, 2006). Its implication in antigen
presentation by MHC class I and II molecules extends its function
to adaptive immunity as well (Nimmerjahn et al., 2003; Dengjel
et al., 2005; Schmid et al., 2006). Besides its role as an intracellular
host defense mechanism against viruses, autophagy can also be
used by the virus for its own proﬁt to replicate more efﬁciently
in cells, or to control cell survival (Espert et al., 2007; Deretic
and Levine, 2009; Espert and Biard-Piechaczyk, 2009; Lunemann
and Munz, 2009; Lin et al., 2010; Sumpter and Levine, 2010). Data
from a genome-wide RNAi screen (Brass et al., 2008) and silencing
of 30 candidate cofactors (Eekels et al., 2011) indicate that HIV-
1 replication in cells requires the presence of several Atg (Atg7,
GABARAPL2, Atg12, and Atg16L). A very recent study underlines
the role of several Atgs, in particular Atg5 and Atg16, in HIV-1
replication in CD4+ T cells (Eekels et al., 2012).
Inductionof autophagy and its regulationduring viral infection
have different biological consequences on pathogen degradation
and on the innate and adaptive immune responses, depending on
both the pathogen and the host cell. The differential regulation of
autophagy by HIV-1 in CD4+T cells and macrophages (presented
below) is only the tip of the iceberg, but demonstrates the impor-
tance of this process duringHIV-1 infection, althoughmany issues
are not fully understood yet.
AUTOPHAGY IN UNINFECTED HIV-1 TARGET CELLS
Autophagy of uninfected CD4+ T cells, when co-cultured with
lymphocytes that express Env, was described for the ﬁrst time
in 2006 (Espert et al., 2006). It is triggered by binding of Env
to its receptors CD4 and CXCR4, but is independent of CD4 or
CXCR4 signaling pathways. Autophagy can be induced in single
cells (hemifusion) and syncytia (complete fusion) and depends
on the fusogenic function of gp41. These results indicate that the
entire process leading to HIV-1 entry into target cells through
binding of Env to its receptors CD4 and CXCR4 is responsible
for autophagy in CD4+ T lymphocytes (Denizot et al., 2008).
As autophagy is gp41-dependent, it can be induced whatever the
coreceptor used for HIV-1 entry (CCR5 or CXCR4; Espert et al.,
2009). The mechanisms by which gp41 induces autophagy are
unknown, but it could be a consequence of the cellular stress
induced after hemifusion of the membranes. A proteomics study
has already demonstrated that rapid and sustained accumulation
of ROS is induced in CD4+ T cells after contact with Env-
expressing cells (Molina et al., 2007), and the production of ROS is
known to be directly involved in autophagy (Scherz-Shouval et al.,
2007).
Importantly, Env-mediated autophagy is required to trigger
CD4+ T cell apoptosis. Indeed, blockade of autophagy at different
steps by drugs (3-methyladenine or BaﬁlomycinA1) or short inter-
fering RNAs against Beclin 1 and Atg7 fully inhibits Env-mediated
apoptosis. At present, nothing is known about the mechanisms
that link autophagy to apoptosis, but Beclin 1 might play a key
role since this Atg also binds to anti-apoptotic Bcl-2 proteins (Bcl-
2 and Bcl-xL). Interaction of Beclin 1 with Bcl-2 or Bcl-xL inhibits
Beclin 1-dependent autophagy, demonstrating a direct crosstalk
between the core machineries regulating autophagy and apoptosis
(Pattingre et al., 2005).
Interestingly, Beclin 1 is accumulated during the early steps
of the Env-induced signaling cascade, and this phenomenon pre-
cedes autophagic vacuolization. Accumulation of Beclin 1 has also
been reported in response to drugs that trigger cell death with
autophagic features (Scarlatti et al., 2004; Shimizu et al., 2004;
Furuya et al., 2005). Deciphering the molecular mechanism of
Beclin 1 accumulation will be a crucial step for understanding the
role of autophagy in HIV-1 pathogenicity.
Conversely, when cells that express HIV-1 R5 or X4 Env
are co-cultured with cells from the monocyte/macrophage lin-
eage, autophagy is not observed in uninfected cells, although
they are susceptible to autophagy induced by different agents.
Env-mediated autophagy is thus a cell-type dependent process.
The state of differentiation is not responsible for their intrinsic
resistance to Env-mediated autophagy because cells at different
stage of differentiation (from promonocytic cells to monocyte-
differentiated macrophages) are all equally resistant. Macrophages
also do not undergo Env-mediated apoptosis and they are resistant
to cell depletion during HIV-1 infection.
These major differences between CD4+ T cells and
macrophages raise unsolved questions: what are the mechanisms
that lead to Env-mediated autophagy, how autophagy is regulated
in the different cell-types, and how autophagy triggers apoptosis
in CD4+ T lymphocytes.
The fact that the fusogenic function of gp41 induces Env-
mediated autophagy only in CD4+ T cells is surprising since
fusion also occurs in uninfected macrophages co-cultured with
HIV-1-infected cells. An important and still unexplained differ-
ence between these two target cells is the ability to form syncytia.
This has been observed since the discovery of the disease and
HIV strains were ﬁrst classiﬁed based on this observation. Indeed
“syncytia-inducing” viruses correspond to HIV-1 strains capable
of infecting CD4+ T cells through CXCR4, while “non-syncytia-
inducing” viruses are HIV-1 strains that infect macrophages
through CCR5 (Goodenow and Collman, 2006). One hypothesis
to explain why Env-mediated autophagy is a cell-speciﬁc mech-
anism is that the gp41-induced perturbations, triggered at the
membrane of both macrophages and CD4+ T cells, could be
different in the two cell-types or differentially regulated. Indeed,
HIV-1 entry in macrophages is supported by additional speciﬁc
interactions with host membrane molecules following Env bind-
ing to the receptor/coreceptor (see HIV-1 Entry in CD4+ T Cells
and Macrophages). HIV-1 can also enter macrophages by endocy-
tosis. Furthermore, recent data have demonstrated that ceramides,
which are known inducers of autophagy (Pattingre et al., 2009),
play an important role in the reorganization of membrane proteins
(Chiantia et al., 2008) that is necessary for HIV-1 entry into cells.
Another hypothesis is that gp120 binding to CD4 and to the core-
ceptor, two steps that precede gp41 insertion into the target mem-
brane, transduces signals that counteract Env-mediated autophagy
in a cell-type dependent manner. We also cannot exclude the
involvement of secreted chemokines and/or cytokines in the regu-
lation of gp41-induced autophagy. Further investigation is needed
to elucidate this point.
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AUTOPHAGY IN INFECTED HIV-1 TARGET CELLS
HIV-1 X4 or R5 Env expression at the cell surface (Env-transfected
or HIV-1-infected cells) triggers autophagy in uninfected CD4+
T cells, leading to apoptosis. Surprisingly, when this contact leads
to a productive infection, Env-mediated autophagy is inhibited
in CD4+ T cells (Zhou and Spector, 2008; Espert et al., 2009).
Moreover, the levels of the autophagy factor LC3-II (Zhou and
Spector, 2008; Espert et al., 2009) and of Beclin 1 (Zhou and
Spector, 2008) are dramatically decreased in these newly infected
CD4+ T cells, suggesting that HIV-1 can actively down-regulate
autophagy. Interestingly, when autophagy is triggered by different
inducers in HIV-1-infected CD4+ T cells, production of HIV-1 is
decreased, suggesting that autophagy can limit HIV-1 replication
(unpublished data from our group).
Thus, HIV-1, as many viruses, can counteract the anti-viral
function of autophagy, but the mechanism(s) by which HIV-1 can
interfere with this essential cellular pathway is (are) still unknown.
One or several viral proteins might block autophagy to avoid
HIV-1 destruction.
Conversely, in cells from the monocyte/macrophage lineage,
autophagy is induced following productive infection through con-
tact with HIV-1 X4 or R5-infected effector cells (Espert et al.,
2009). However, the observation that viruses are present only
in moderately autophagic cells (Espert et al., 2009), suggests
that autophagy is still controlled by HIV-1 in these cells to
avoid degradation. Interestingly, early, non-degradative steps of
autophagy promote HIV-1 production since blockade of this
process dramatically decreases the quantity of p24 Gag (Espert
et al., 2009; Kyei et al., 2009). In addition, the HIV-1 precursor
Gag is found in complexes with LC3 and is present at LC3-II-
enriched membranes, suggesting that autophagy could favor Gag
processing and thus production of viral particles (Kyei et al.,
2009). In contrast, the degradative step of autophagy has an
anti-HIV-1 activity that must be controlled by the virus to pre-
vent its degradation. Indeed, blockage of the degradative step
of autophagy increases HIV-1 production (Espert et al., 2009;
Kyei et al., 2009). Interestingly, the auxiliary HIV-1 protein Nef
plays a major role in the inhibition of the degradative stage of
autophagy by binding to Beclin 1 (Kyei et al., 2009). Nef also
interacts with immunity-associated GTPase family M (IRGM),
a protein known to play an autophagy-dependent anti-bacterial
function (Deretic et al., 2006; McCarroll et al., 2008; Deretic,
2010a; Singh et al., 2010) and to bind to several key proteins of the
autophagy process such as Atg5 andAtg10 (Pombo-Grégoire et al.,
2011). Nef/IRGM interaction promotes autophagosome accumu-
lation and improves HIV-1 replication (Pombo-Grégoire et al.,
2011). In contrast, its absence is detrimental for the viral pro-
duction. IRGM also triggers autophagy in cells infected by other
RNA viruses, such as hepatitis C virus (HCV) and measles virus
(MeV), suggesting that different RNA virus families use similar
strategies, involving IRGM, to ﬁne-tune autophagy to their own
beneﬁt.
Taken together, all these results (summarized in Table 2) sug-
gest a complex, cell-type speciﬁc relationship between HIV-1 and
the autophagic response and highlight the complexity of HIV-1
pathogenesis.
Table 2 | Regulation of autophagy in CD4+T lymphocytes and macrophages during HIV-1 infection.
Uninfected Infected Autophagy
C
D
4+
T
ly
m
ph
oc
yt
es
Uninfected cells
Autophagy leads to
apoptotic cell death
contributing to AIDS
Productively
infected cells
Autophagy is
blocked favoring
HIV-1 replication
M
ac
ro
ph
ag
es
Uninfected cells
Autophagy is not
induced
Macrophages are
not depleted during
HIV-1 pathogenesis
Productively
infected cells
Autophagy is
induced and blocked
favoring HIV-1
replication
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CONCLUSION
Although autophagy is now acknowledged to have a major role
in HIV-1 infection, the available data are still quite fragmentary
and more research work is needed to clarify the contribution
of autophagy to viral replication, host immune responses, and
viral pathogenesis. The available data indicate that autophagy is
an anti-viral process and as such is inhibited by HIV-1 to avoid
degradation and to promote replication. However, autophagy is
also used by HIV-1 for its replication, especially in macrophages
where autophagy is present all along the productive infection
period.
Based on the current knowledge on the role of autophagy
in different viral infections, several hypotheses can be pro-
posed on how HIV-1 uses autophagy for its own proﬁt in
macrophages: (i) autophagy could be required to transport the
RTC to the MTOC using the microtubule network. Indeed, the
RTC and autophagosomes that are formed in the cytoplasm
use the microtubule network to trafﬁc toward the MTOC to
reach the nucleus and to fuse with late endosomes or lysosomes,
respectively (Afonso et al., 2007; Jahreiss et al., 2008; Orsi et al.,
2009; Geeraert et al., 2010); (ii) autophagy could be a mech-
anism for membrane remodeling to support viral replication
and assembly, as already described for other viruses (Miller and
Krijnse-Locker, 2008). The fact that HIV-1 Gag-derived proteins
interact with LC3 suggests that autophagy plays a role in pro-
moting certain steps of HIV biogenesis (Kyei et al., 2009); (iii)
autophagy could be used to speciﬁcally degrade host cell pro-
teins that are important for the defense against HIV-1, in asso-
ciation with the ubiquitin–proteasome system through adapter
proteins, such as p62/SQSTM1 and NBR1 (Kirkin et al., 2009;
Lamark et al., 2009; Deretic, 2010b); (iv) low levels of autophagy
may promote the formation of latent cell reservoirs; and (v)
autophagy could process antigen determinants for their presen-
tation by the MHC, and could hide HIV-1 from recognition by the
immune system. This point is discussed in other chapters of this
issue.
In addition, autophagy is a cell fate-determining process that
triggers apoptosis of bystander CD4+ T cells that cannot be
productively infected by HIV-1. Inhibition of autophagy in pro-
ductively infected CD4+ T cells may thus both prevent HIV-1
degradation and maintain cell viability long enough to allow efﬁ-
cient viral replication. Autophagy has been deﬁned as a type II
programmed cell death, based on the morphology of the dying
cells. However, Env-mediated autophagy is not a cell death mecha-
nismby itself as it leads to apoptosis by a yet unknownmechanism.
It is important to note that autophagy deregulation may also play
a role in a variety of diseases that are related directly and/or indi-
rectly toHIV infection, including cancer, dementia, and premature
aging.
To the best of our knowledge, HIV-1 infection of CD4+ T cells
and macrophages is the ﬁrst example of a viral infection in which
autophagy governs both viral replication and the fate of uninfected
cells. The data also strongly suggest that autophagy is responsible,
at least in part, for HIV-1 pathogenesis, providing new insights
into therapeutic strategies for the future.
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